Search for Clinical Trial Results
Neurofibrosarcoma - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors Condition: Peripheral Nerve Tumors Date: 2016-11-21 Interventions: Drug: CPI-0610
|
Recruiting |
Study Name: Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Condition:
Date: 2014-08-06 Interventions:
|
Completed |
Study Name: Sorafenib and Dacarbazine in Soft Tissue Sarcoma Condition:
|
Recruiting |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition:
|
Terminated |
Study Name: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) Condition:
|
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition:
|
Recruiting |
Study Name: Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Condition:
|
Active, not recruiting |
Study Name: Trial of Dasatinib in Advanced Sarcomas Condition:
Date: 2007-04-20 Interventions: Drug: Dasatinib oral agent, continuous dosing, Cycles = 28 days |
Completed |
Study Name: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Condition:
|